People In Brief: Pfizer, Valeant, Vitalah, Aker, Mulberry Love
This article was originally published in The Tan Sheet
Executive Summary
Schulman out, Bourla in at Pfizer; Valeant appoints Kellen chairman; Vitalah VP leads Oxylent sales; Aker names Australia head; CRN builds regulatory team; more People In Brief.